Advertisement

Topics

Bayer's Inhaled Cipro For Bronchiectasis To Face FDA Panel Efficacy Questions

12:46 EST 14 Nov 2017 | SCRIP

Advisory committee asked to opine on whether there is substantial evidence of efficacy even though Phase III studies missed on...

      

Related Stories

 

Original Article: Bayer's Inhaled Cipro For Bronchiectasis To Face FDA Panel Efficacy Questions

NEXT ARTICLE

More From BioPortfolio on "Bayer's Inhaled Cipro For Bronchiectasis To Face FDA Panel Efficacy Questions"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...